Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.51% | -0.39% | -1.00% | 3.55% | 4.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.51% | -0.39% | -1.00% | 3.55% | 4.20% |
| Cost of Revenue | 0.89% | 2.41% | -4.92% | 4.72% | 3.15% |
| Gross Profit | -2.63% | -1.81% | 1.11% | 2.97% | 4.71% |
| SG&A Expenses | -28.78% | -7.68% | 3.32% | -38.87% | 40.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.79% | -3.56% | -0.35% | -11.53% | 19.55% |
| Operating Income | 98.42% | 15.09% | -4.09% | 47.75% | -45.10% |
| Income Before Tax | 86.09% | 18.44% | 19.47% | -154.87% | -37.34% |
| Income Tax Expenses | 28.64% | 59.97% | 49.23% | -582.85% | 30.44% |
| Earnings from Continuing Operations | 125.99% | 8.94% | 13.65% | -143.55% | -53.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 125.99% | 8.94% | 13.65% | -143.55% | -53.96% |
| EBIT | 98.42% | 15.09% | -4.09% | 47.75% | -45.10% |
| EBITDA | 52.91% | 6.77% | -7.46% | 34.21% | -32.44% |
| EPS Basic | 127.53% | 10.76% | 15.90% | -144.47% | -53.98% |
| Normalized Basic EPS | 90.99% | 20.43% | -1.90% | 61.01% | -41.00% |
| EPS Diluted | 128.57% | 9.09% | 14.29% | -145.25% | -54.84% |
| Normalized Diluted EPS | 91.48% | 21.16% | -0.87% | 62.97% | -40.39% |
| Average Basic Shares Outstanding | -0.66% | -1.64% | -1.93% | -1.87% | 0.04% |
| Average Diluted Shares Outstanding | -0.97% | -2.26% | -2.95% | -3.05% | -0.97% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.56% | -0.10% | -0.14% | -3.25% | 1.17% |